MRTX
Mirati Therapeutics, Inc. Common Stock
MRTX
MRTX
Delisted
MRTX was delisted on the 22nd of January, 2024.
233 hedge funds and large institutions have $2.95B invested in Mirati Therapeutics, Inc. Common Stock in 2022 Q4 according to their latest regulatory filings, with 43 funds opening new positions, 99 increasing their positions, 72 reducing their positions, and 47 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
233
Holders Change
-10
Holders Change %
-4.12%
% of All Funds
3.76%
Holding in Top 10
10
Holding in Top 10 Change
-5
Holding in Top 10 Change %
-33.33%
% of All Funds
0.16%
New
43
Increased
99
Reduced
72
Closed
47
Calls
$86.2M
Puts
$34.1M
Net Calls
+$52.2M
Net Calls Change
+$69.3M
Top Buyers
| 1 |
RI
1
RTW Investments
New York
|
$165M |
| 2 |
AC
2
Armistice Capital
New York
|
$158M |
| 3 |
3
State Street
Boston,
Massachusetts
|
$115M |
| 4 |
4
Morgan Stanley
New York
|
$76.6M |
| 5 |
5
Point72 Asset Management
Stamford,
Connecticut
|
$34.1M |
